Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1811111Generated: November 2, 2026

Hydrochloric Acid → HCID 66606358, compound

https://huagongshe.com/reaction/1811111

Reaction equation

Participants

RoleNameHCIDCharge
ReactantHydrochloric AcidHCID 313—
ReactantPotassium Phosphate, TribasicHCID 62657—
ReactantHCID 66606411HCID 66606411—
ReactantHCID 66606546HCID 66606546—
CatalystHCID 178418397HCID 178418397—
SolventEthanolHCID 702—
SolventTolueneHCID 1140—
ProductHCID 66606358HCID 66606358—

Reaction Conditions

Temperature100 °C

Reaction Steps

A mixture of 5-bromo-2-(hydroxymethyl)-2,3,4,9-tetrahydro-1H-carbazole-8-carboxamide (Intermediate 30-3(a), 50 mg, 0.155 mmol), 5-tert-butyl-2-(2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)isoindoline-1,3-dione (Intermediate 50-11, 97 mg, 0.232 mmol), 2 M aqueous tripotassium phosphate (0.232 mL, 0.464 mmol), and tetrakis(triphenylphosphine)palladium (8.9 mg, 7.7 μmol) in toluene (3 mL) and ethanol (1 mL) was heated at 100° C. in a sealed tube overnight. The mixture was cooled to rt, treated with 1 M hydrochloric acid, extracted with EtOAc, and the organic phase was dried and concentrated to provide 5-tert-butyl-2-(3-(8-carbamoyl-2-(hydroxymethyl)-2,3,4,9-tetrahydro-1H-carbazol-5-yl)-2-methylphenylcarbamoyl)benzoic acid (Mass spectrum m/z 554.4 (M+H)+). Without purification, this material was dissolved in acetic acid (4 mL) and heated at 100° C. for 2 h, then was concentrated. The residue was purified by column chromatography (eluting with a gradient from DCM to 90:9:1 DCM-methanol-28% aqueous ammonium hydroxide), followed by purification by preparative HPLC. The appropriate effluent fractions were made basic with NaHCO3 (aq) and extracted with DCM, dried and concentrated to provide 5-(3-(5-tert-butyl-1,3-dioxoisoindolin-2-yl)-2-methylphenyl)-2-(hydroxymethyl)-2,3,4,9-tetrahydro-1H-carbazole-8-carboxamide (Example 31-2) as a light yellow solid (18 mg, 18%). 1H NMR (400 MHz, chloroform-d) δ 10.05 (1 H, s), 7.98-8.02 (1 H, m), 7.86-7.91 (1 H, m), 7.79-7.84 (1 H, m), 7.33-7.45 (4 H, m), 7.24-7.28 (2 H, m), 6.89-6.94 (1 H, m), 3.56-3.71 (2 H, m), 2.91 (1 H, dd, J=16.70, 4.83 Hz), 2.48-2.61 (1 H, m), 1.99-2.10 (2 H, m), 1.88-1.99 (2 H, m), 1.86 (3 H, s), 1.43-1.55 (2 H, m), 1.41 (9 H, s). Mass spectrum m/z 536.3 (M+H)+. Also obtained was (5-(3-(5-tert-butyl-1,3-dioxoisoindolin-2-yl)-2-methylphenyl)-8-carbamoyl-2,3,4,9-tetrahydro-1H-carbazol-2-yl)mEtOAc (Example 31-3) as a light yellow solid (15 mg, 14%). 1H NMR (400 MHz, chloroform-d) δ 10.05 (1 H, s), 7.97-8.05 (1 H, m), 7.86-7.91 (1 H, m), 7.79-7.84 (1 H, m), 7.33-7.41 (3 H, m), 7.26-7.28 (1 H, m), 4.00-4.13 (2 H, m), 2.90 (2 H, td, J=10.88, 5.05 Hz), 2.46-2.71 (2 H, m), 2.12-2.34 (2 H, m), 2.08 (4 H, s), 1.87 (3 H, d, J=7.03 Hz), 1.45-1.54 (1 H, m), 1.41 (9 H, s). Mass spectrum m/z 578.3 (M+H)+.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08362065B2
Source datasetuspto-grants-2013_01
ORD IDord-6554bddc52a544ce9b6d58c928954002
Source noteuspto-grants-2013_01